IGF2BP2 and gastric cancer: In a case series of 407 gastric cancer patients [35], auto-antibodies against nine antigens were detected (c-Myc, p16, HSPD1, PTEN, p53, NPM1, ENO1, p62, HCC1.4), while in another series, an optimal prediction model with six TAAs (p62, c-Myc, NPM1, 14-3-3ζ, MDM2, and p16) was designed [36].